Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the treatment of HER2-positive early breast cancer: Final analysis of 488 patients in the international, randomised, two-cohort PrefHer study

Affiliation auteurs!!!! Error affiliation !!!!
TitrePatients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the treatment of HER2-positive early breast cancer: Final analysis of 488 patients in the international, randomised, two-cohort PrefHer study
Type de publicationJournal Article
Year of Publication2014
AuteursPivot X., Gligorov J., Mueller V., Barrett-Lee P., Knoop A., Curigliane G., Jenkins V., Scotto N., Osborne S., Fallowfield L.
JournalEUROPEAN JOURNAL OF CANCER
Volume50
PaginationS109-S110
Date PublishedMAR
Type of ArticleMeeting Abstract
ISSN0959-8049